Press Releases

Press Releases

Filters
Viatris Inc. to Participate in BofA Global Healthcare Conference
Viatris Inc. to Participate in Citi's 16th Annual BioPharma Conference
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
Mylan Wins Dismissal of Kansas EpiPen® Direct Purchaser Case
Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021
Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action
Viatris Inc. to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
Viatris Inc. Releases Inaugural Sustainability Report, Reinforcing its Commitment to Better Health and Better Communities Worldwide
Viatris Inc. to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
Viatris Inc. to Participate in BofA Securities 2021 Health Care Conference
Displaying 1 - 10 of 23